My proposal is that patients with hematuria, thin GBM, and a mutation inCOL4A3, COL4A4, orCOL4A5 have a form of Alport syndrome and that patients without such mutations have “hematuria with thin GBM”. The gene discussed is COL4A4; the disease is Alport syndrome.